论文部分内容阅读
河北省科委聘请国内著名医药学专家组成鉴定委员会,于1996年9月21日对国家新药研究基金项目“中药通心络胶囊治疗冠心病心绞痛的研究”进行了科技成果鉴定。通过专家严格审查和技术答辨,一致认为:①“中药通心络胶囊治疗冠心病心绞痛的研究”立题有新意,组方合理而且独特,科研设计严谨,统计数据可靠,技术资料完备,具有科学性。②本项研究在国内首先运用中医络病理论探讨冠心病心绞痛的中医病理机制,提出心气虚乏,络脉瘀阻,绌急而痛的病机新
The Hebei Provincial Science and Technology Commission hired well-known experts in medicine to form an appraisal committee. On September 21, 1996, the National New Drug Research Fund Project “Research on Traditional Chinese Medicine Tongxinluo Capsule in the Treatment of Coronary Heart Disease Angina Pectoris” was conducted to identify scientific and technological achievements. Through expert rigorous review and technical analysis, it was agreed that: 1 “Research on traditional Chinese medicine Tongxinluo capsules for the treatment of angina pectoris of coronary heart disease” has new ideas, reasonable and unique composition, strict scientific research and design, reliable statistical data, and complete technical data. scientific. 2 This study first used TCM theory to explore the TCM pathological mechanism of angina pectoris of coronary heart disease, and put forward a new pathogenesis of qi deficiency, collaterals and phlegm, and urgency and pain.